Sophie Abgrall

2.6k total citations
46 papers, 733 citations indexed

About

Sophie Abgrall is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Sophie Abgrall has authored 46 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 20 papers in Epidemiology and 17 papers in Virology. Recurrent topics in Sophie Abgrall's work include HIV/AIDS Research and Interventions (28 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (16 papers). Sophie Abgrall is often cited by papers focused on HIV/AIDS Research and Interventions (28 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (16 papers). Sophie Abgrall collaborates with scholars based in France, United States and Canada. Sophie Abgrall's co-authors include Dominique Costagliola, Sophie Grabar, Hana Selinger‐Leneman, Laurence Weiss, Gilles Pialoux, Julia del Amo, Sophie Matheron, Marguerite Guiguet, Antonella d’Arminio Monforte and Olivier Bouchaud and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Sophie Abgrall

45 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sophie Abgrall France	16	469	296	293	184	73	46	733
Bruno Hoën France	14	463 1.0×	272 0.9×	359 1.2×	129 0.7×	75 1.0×	24	799
Junko Tanuma Japan	19	814 1.7×	430 1.5×	330 1.1×	274 1.5×	68 0.9×	77	1.2k
Marialuisa Partisani France	15	598 1.3×	351 1.2×	297 1.0×	391 2.1×	80 1.1×	38	1.1k
Christian Manzardo Spain	18	607 1.3×	398 1.3×	368 1.3×	167 0.9×	75 1.0×	54	959
Selvamuthu Poongulali India	14	462 1.0×	206 0.7×	217 0.7×	127 0.7×	69 0.9×	46	696
Herman G. Sprenger Netherlands	13	624 1.3×	223 0.8×	391 1.3×	396 2.2×	54 0.7×	41	994
Jacques Gilquin France	13	447 1.0×	315 1.1×	428 1.5×	402 2.2×	138 1.9×	33	963
Kathleen Squires United States	11	432 0.9×	267 0.9×	325 1.1×	263 1.4×	93 1.3×	17	817
Cloete van Vuuren South Africa	15	488 1.0×	273 0.9×	256 0.9×	71 0.4×	123 1.7×	29	826
Nicoletta Ladisa Italy	23	732 1.6×	356 1.2×	543 1.9×	298 1.6×	70 1.0×	69	1.2k

Countries citing papers authored by Sophie Abgrall

Since Specialization

Citations

This map shows the geographic impact of Sophie Abgrall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Abgrall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Abgrall more than expected).

Fields of papers citing papers by Sophie Abgrall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Abgrall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Abgrall. The network helps show where Sophie Abgrall may publish in the future.

Co-authorship network of co-authors of Sophie Abgrall

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Abgrall. A scholar is included among the top collaborators of Sophie Abgrall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Abgrall. Sophie Abgrall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Épaulard, Olivier, Sophie Abgrall, Jean‐François Faucher, et al.. (2022). Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection. Clinical Microbiology and Infection. 28(12). 1629–1635. 8 indexed citations

Maïga, Almoustapha Issiaka, et al.. (2020). Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?. PLoS ONE. 15(9). e0238687–e0238687. 7 indexed citations

Trickey, Adam, Ard van Sighem, John Stover, et al.. (2019). Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings. AIDS. 33(Supplement 3). S271–S281. 4 indexed citations

Grabar, Sophie, Hana Selinger‐Leneman, Sophie Abgrall, et al.. (2017). Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4. PLoS ONE. 12(10). e0184441–e0184441. 14 indexed citations

Matheron, Sophie, Jacques Gilquin, Juliette Pavie, et al.. (2016). Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France. AIDS. 30(14). 2235–2246. 10 indexed citations

Dray‐Spira, Rosemary, Pierre de Truchis, Sophie Grabar, et al.. (2015). Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France. PLoS ONE. 10(3). e0118492–e0118492. 7 indexed citations

Makinson, Alain, Sabrina Eymard‐Duvernay, F. Raffi, et al.. (2015). Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers. AIDS. 30(4). 573–582. 30 indexed citations

Abgrall, Sophie, Antoine Rachas, Jérôme Tourret, et al.. (2015). A Multifaceted Intervention Designed to Improve Medical Management of Moderate to Advanced Chronic Kidney Disease in HIV-Infected Patients: A Cluster Randomized Trial. Clinical Infectious Diseases. 61(3). 375–384. 3 indexed citations

Abgrall, Sophie, Lionel Fugon, Michelle Bentata, et al.. (2013). Visiting One’s Native Country. Journal of the International Association of Providers of AIDS Care (JIAPAC). 12(6). 407–413. 13 indexed citations

10.

Hogg, Robert S., Margaret May, Sophie Abgrall, et al.. (2011). The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Medicine. 13(2). 89–97. 44 indexed citations

11.

Murphy, Richard A., et al.. (2011). Multidrug-Resistant Chronic Osteomyelitis Complicating War Injury in Iraqi Civilians. The Journal of Trauma: Injury, Infection, and Critical Care. 71(1). 252–254. 27 indexed citations

12.

Kousignian, Isabelle, Odile Launay, C Mayaud, et al.. (2009). Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?. Journal of Antimicrobial Chemotherapy. 65(1). 138–144. 2 indexed citations

13.

Grabar, Sophie, Hana Selinger‐Leneman, Sophie Abgrall, et al.. (2009). Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. AIDS. 23(9). 1163–1169. 136 indexed citations

14.

Sterne, Jonathan A C, Sophie Abgrall, François Dabis, et al.. (2008). Prognostic Importance of Anaemia in HIV Type-1-Infected Patients Starting Antiretroviral Therapy: Collaborative Analysis of Prospective Cohort Studies. Antiviral Therapy. 13(8). 959–967. 66 indexed citations

15.

Kousignian, Isabelle, Sophie Abgrall, Sophie Grabar, et al.. (2007). Maintaining Antiretroviral Therapy Reduces the Risk of AIDS-Defining Events in Patients with Uncontrolled Viral Replication and Profound Immunodeficiency. Clinical Infectious Diseases. 46(2). 296–304. 12 indexed citations

16.

Abgrall, Sophie, Patrick Yéni, Olivier Bouchaud, & Dominique Costagliola. (2006). Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir. AIDS. 20(16). 2099–2106. 8 indexed citations

17.

Abgrall, Sophie, Patrick Yéni, Olivier Bouchaud, & Dominique Costagliola. (2006). Comparative Biological and Clinical Outcomes after a Switch from a Virologically Unsuccessful First Protease Inhibitor–Containing Antiretroviral Combination to a 3‐Drug Regimen Containing Efavirenz, Nevirapine, or Abacavir. Clinical Infectious Diseases. 44(1). 120–127. 3 indexed citations

18.

Kousignian, Isabelle, Sophie Abgrall, Xavier Duval, et al.. (2003). Modeling the Time Course of CD4 T-Lymphocyte Counts According to the Level of Virologic Rebound in HIV-1–Infected Patients on Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(1). 50–57. 18 indexed citations

19.

Abgrall, Sophie, Luc Mouthon, Pascal Cohen, et al.. (2001). Localized neurological necrotizing vasculitides. Three cases with isolated mononeuritis multiplex.. PubMed. 28(3). 631–3. 16 indexed citations

20.

Abgrall, Sophie, Sophie Matheron, Vincent Le Moing, Caroline Dupont, & Dominique Costagliola. (2001). Pneumocystis carinii Pneumonia Recurrence in HIV Patients on Highly Active Antiretroviral Therapy: Secondary Prophylaxis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(2). 151–158. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact